Concepedia
Statistics
Publications
20
Citations
1.7K
H-Index
18
Active since
1983
Affiliations
National Cancer Institute(Current)
National Institutes of Health
National Institutes of Health Clinical Center
G Bryant is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.
Publications per year
1983–1995
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.
Wyndham H. Wilson, G Bryant, Susan E. Bates et al. · Journal of Clinical Oncology · 1993 · 246 citations
Medicine, Oncology, Pharmacology +17
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
Wyndham H. Wilson, Stacey L. Berg, G Bryant et al. · Journal of Clinical Oncology · 1994 · 217 citations
Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
David Colcher, Jorge A. Carrasquillo, Paul H. Sugarbaker et al. · PubMed · 1987 · 164 citations
Medicine, Oncology, Pharmacology +16
Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3
David Colcher, Ann D. Thor, Jeffrey Schlom et al. · International Journal of Cancer · 1987 · 125 citations
Medicine, Nuclear Medicine, Oncology +17
Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients.
David Colcher, Jorge A. Carrasquillo, Paul H. Sugarbaker et al. · PubMed · 1987 · 124 citations
1–5 of 20